Meta Biomed America Revenue and Competitors
Estimated Revenue & Valuation
- Meta Biomed America's estimated annual revenue is currently $3.7M per year.
- Meta Biomed America's estimated revenue per employee is $206,667
Employee Data
- Meta Biomed America has 18 Employees.
- Meta Biomed America grew their employee count by -10% last year.
Meta Biomed America's People
Name | Title | Email/Phone |
---|---|---|
1 | Business Development Manager | Reveal Email/Phone |
Meta Biomed America Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 7 | -12% | N/A | N/A |
#2 | $4M | 38 | 81% | N/A | N/A |
#3 | N/A | 76 | 27% | N/A | N/A |
#4 | $0.9M | 5 | 0% | N/A | N/A |
#5 | $1.1M | 8 | 33% | N/A | N/A |
#6 | $10.9M | 61 | 7% | N/A | N/A |
#7 | $0.7M | 9 | 29% | N/A | N/A |
#8 | $4M | 20 | -5% | N/A | N/A |
#9 | $1.7M | 11 | 22% | N/A | N/A |
#10 | $7.6M | 49 | 2% | N/A | N/A |
What Is Meta Biomed America?
Since its establishment in 1990, Meta Biomed has focused all its efforts in the development of new technologies for the health & medical industry. As a result of the ceaseless effort to increase the investment in Research & Development, Meta Biomed began to produce not only Dental Materials & Equipment but also an excellent array of absorbable multifilament and monofilament materials for the Suture industry. As a specialized manufacturer in the advanced Bio-Tech field, Meta Biomed has continued to pursue new technologies and now the company has patents on synthetic bone graft materials and other Bio-Materials. Currently, Meta Biomed exports its products to about 80 countries including the United States and Europe.
keywords:N/AN/A
Total Funding
18
Number of Employees
$3.7M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.7M | 19 | -10% | N/A |
#2 | N/A | 21 | 5% | N/A |
#3 | $4.3M | 24 | 4% | N/A |
#4 | $7.1M | 28 | -10% | N/A |
#5 | $4.3M | 35 | 17% | N/A |